Trial Profile
A prospective, multicentre, open-label, single arm observational study of Concor treatment in Asian patients with Essential Hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Feb 2017
Price :
$35
*
At a glance
- Drugs Bisoprolol (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Merck & Co
- 07 Dec 2010 New trial record